Concord Drugs informs about disclosure

Concord Drugs has informed that the exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for S Manoj Kumar Reddy.

The above information is a part of company’s filings submitted to BSE.